IN2014DN06213A - - Google Patents
Info
- Publication number
- IN2014DN06213A IN2014DN06213A IN6213DEN2014A IN2014DN06213A IN 2014DN06213 A IN2014DN06213 A IN 2014DN06213A IN 6213DEN2014 A IN6213DEN2014 A IN 6213DEN2014A IN 2014DN06213 A IN2014DN06213 A IN 2014DN06213A
- Authority
- IN
- India
- Prior art keywords
- linezolid
- isomer
- relative
- hydroxide
- provides
- Prior art date
Links
- TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 abstract 9
- 229960003907 linezolid Drugs 0.000 abstract 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 3
- 239000013078 crystal Substances 0.000 abstract 1
- -1 linezolid compound Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN6213DEN2014 IN2014DN06213A (en:Method) | 2012-01-24 | 2013-01-22 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2254DE2012 | 2012-07-19 | ||
| PCT/IB2013/050537 WO2013111048A1 (en) | 2012-01-24 | 2013-01-22 | Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent |
| IN6213DEN2014 IN2014DN06213A (en:Method) | 2012-01-24 | 2013-01-22 | |
| IN267DE2012 IN2012DE00267A (en:Method) | 2012-01-31 | 2013-01-22 | |
| IN200DE2012 IN2012DE00200A (en:Method) | 2012-01-24 | 2013-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06213A true IN2014DN06213A (en:Method) | 2015-10-23 |
Family
ID=47884428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6213DEN2014 IN2014DN06213A (en:Method) | 2012-01-24 | 2013-01-22 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20150025236A1 (en:Method) |
| EP (1) | EP2852580A1 (en:Method) |
| IN (1) | IN2014DN06213A (en:Method) |
| WO (1) | WO2013111048A1 (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108117527A (zh) * | 2018-01-12 | 2018-06-05 | 上海龙翔生物医药开发有限公司 | 一种适用于工业化生产的利奈唑胺晶型ⅰ制备方法 |
| CN119119019A (zh) * | 2024-09-11 | 2024-12-13 | 遵义医科大学 | 一种杂环磺酰胺/磺酸酯衍生物及其制备方法、应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115155A (en) * | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| EP1114819B1 (en) | 1996-04-11 | 2008-01-09 | Pharmacia & Upjohn Company LLC | Process to prepare oxazolidinones |
| DE69837615T2 (de) | 1997-11-07 | 2007-12-27 | Pharmacia & Upjohn Co. Llc, Kalamazoo | Verfahren zur herstellung von oxazolidinonen |
| US6444813B2 (en) | 2000-02-02 | 2002-09-03 | Pharmacia & Upjohn Company | Linezolid-crystal form II |
| AR027261A1 (es) | 2000-02-02 | 2003-03-19 | Upjohn Co | Linezolid forma cristalina ii |
| EP2902386B1 (en) | 2003-10-16 | 2020-04-08 | Symed Labs Limited | A crystalline form of linezolid |
| US7291614B2 (en) | 2005-02-24 | 2007-11-06 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| US20090093631A1 (en) | 2007-09-06 | 2009-04-09 | Ben-Zion Dolitzky | Processes for the preparation of a linezolid intermediate, linezolid hydroxide |
| WO2009063505A2 (en) * | 2007-10-08 | 2009-05-22 | Usv Limited | Process for preparation of (s) (n-[[3-[3-fluoro-4-(4-morpholinyl) hen l -2-oxo-5-oxazolidin l methyl]acetamide |
| WO2010084514A2 (en) | 2009-01-02 | 2010-07-29 | Neuland Laboratories Ltd. | A process for the preparation of (5s)-(n)-[[3-[3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide |
| WO2011050826A1 (en) * | 2009-10-28 | 2011-05-05 | Synthon B.V. | Process for making crystalline form a of linezolid |
| EP2516408A1 (en) * | 2009-12-26 | 2012-10-31 | Alembic Pharmaceuticals Limited | Process for the preparation of linezolid |
| WO2011114210A2 (en) | 2010-03-15 | 2011-09-22 | Jubilant Life Sciences Limited | Processes for the preparation of linezolid |
| WO2014013498A1 (en) * | 2012-07-17 | 2014-01-23 | Symed Labs Limited | Amorphous coprecipitates of linezolid |
-
2013
- 2013-01-22 EP EP13709542.8A patent/EP2852580A1/en not_active Withdrawn
- 2013-01-22 US US14/374,213 patent/US20150025236A1/en not_active Abandoned
- 2013-01-22 WO PCT/IB2013/050537 patent/WO2013111048A1/en active Application Filing
- 2013-01-22 IN IN6213DEN2014 patent/IN2014DN06213A/en unknown
-
2016
- 2016-11-18 US US15/356,374 patent/US20170066728A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2852580A1 (en) | 2015-04-01 |
| US20170066728A1 (en) | 2017-03-09 |
| WO2013111048A1 (en) | 2013-08-01 |
| US20150025236A1 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013501199A1 (en) | Photochromic compounds and compositions | |
| NZ739757A (en) | Processes for preparing jak inhibitors and related intermediate compounds | |
| NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
| IN2014MN01521A (en:Method) | ||
| MX340125B (es) | 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento. | |
| EP2590649A4 (en) | PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES | |
| MX350211B (es) | Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico. | |
| IN2014DN10617A (en:Method) | ||
| MX377930B (es) | Proceso para fabricar compuestos de quinolona. | |
| BR112014004523A2 (pt) | composto e composição aromatizante | |
| IN2014DN00144A (en:Method) | ||
| WO2018125983A8 (en) | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors | |
| WO2013190455A3 (en) | Process for the preparation of lurasidone hydrochloride | |
| IN2013MU03442A (en:Method) | ||
| IN2014MN00976A (en:Method) | ||
| MX342273B (es) | Proceso para la preparacion de esteres de acido (5-fluoro-2-metil-3-quinolina-2-ilmetil-indol-1-il)-acetico. | |
| EA201201293A1 (ru) | Гидрат гидробромида агомелатина и его получение | |
| IN2014DN06213A (en:Method) | ||
| BR112015015880A2 (pt) | processo para a produção do composto, composto de fórmula, preparação farmacêutica e compostos, composições, métodos e utilizações substancialmente inovadores | |
| SG10201901578UA (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| JO2812B1 (en) | A method of obtaining the aggregate V crystal form of agomelatine | |
| MX2013004193A (es) | Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico. | |
| NZ711329A (en) | A process for preparation of (2s, 5r)- sulfuric acid mono-{ [(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester | |
| NZ606574A (en) | Novel synthesis for thiazolidinedione compounds | |
| IN2012DE00200A (en:Method) |